FDA Rationale for Recognition Decision: Meropenem

Currently, there are no FDA-recognized susceptibility test interpretive criteria (breakpoints) for meropenem for Acinetobacter spp.

Source: FDA Center for Drug Evaluation and Research - What's New - January 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news